Nail on the head there Red... well summarized.. should reassure...

First 49 Last

Share
Profile

Follow
perthcheetah

528 Posts.

180

20/03/19

12:12

Post #: 37822575
Share

Originally posted by redlake: ↑

As someone may once have said, the only certainties in life are taxes, death and capital raises.

It would definitely be good to get the iron ore project in a JV with some cash up front. I'm sure that's what management was hoping for. For whatever reason it hasn't happened yet and the Salobo licence hasn't come through yet either. Both these events would have put a rocket under the SP and meant any CR that was necessary could have been done at a far higher price.

So we face another CR. Unfortunate, but a fact of life in this niche. In my view the dilution effect of capital raises is vastly overstated. It’s not as though we’re giving millions of shares away for nothing to some no-good directors. We are actually getting valuable money for them. Slight dilution admittedly as they’re at a discount. But this raise will give us another $1.6 million in the bank and I’m sure it’ll be used wisely (unlike some other companies I’ve been involved with). From what I have seen we have a pretty astute and fast-working management team and we have lots of positives that we should not lose sight of:

--- Itapitanga, already JV’d, this will bring in a very considerable stream of money once into production

--- Salobo, no fault of management that they’ve had to go the long way round to get this permit and there’s little they can do to speed up the process. They just have to wait till the authorities are ready. As and when it does come through at least we’ll have the money we need for further exploration and drilling.

--- Jambreiro, management give every impression they are working hard to get this JV’d asap. This will add another income stream to Itapitanga once into production – which shouldn’t take long - and will hopefully deliver a fat wad of money up front.

--- Management has already shown that they can pick winners, so maybe more coming up in the future.

Lots of positives here, but the biggest positive of all is our management team. They’re doing what they have to do to build this company – even if it takes time to see the rewards.

Expand

Nail on the head there Red... well summarized.. should reassure the "nervous nellies" and bring their focus back to the big picture and what managements vision is for CTM...although if SH cannot see the bigger picture then either this stock is not for you or this game is certainly not for you..

CTM Price at posting: 0.7¢ Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

PL3

Patagonia looks to raise $2.15M for South American exploration and development

There are more pages in this discussion • 1 more message in this thread...

First 49 Last

Add CTM (ASX) to my watchlist

(20min delay)
Last 46.0¢		Change 0.035(8.24%)		Mkt cap ! $228.2M

Open	High	Low	Value	Volume
43.5¢	47.0¢	43.5¢	$193.3K	425.6K

Buyers (Bids)

No.	Vol.	Price($)
7	103252	42.5¢

Sellers (Offers)

Price($)	Vol.	No.
46.0¢	7907	1

View Market Depth

No.	Vol.	Price($)
7	103252	0.425
3	142190	0.420
2	107500	0.415
4	121317	0.410
5	47500	0.405

Price($)	Vol.	No.
0.460	7907	1
0.465	24262	3
0.470	36350	4
0.475	72053	2
0.480	67246	2

Last trade - 16.10pm 09/07/2024 (20 minute delay)

CTM (ASX) Chart

Nail on the head there Red... well summarized.. should reassure...

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Patagonia looks to raise $2.15M for South American exploration and development

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Nail on the head there Red... well summarized.. should reassure...

Top Stories

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Patagonia looks to raise $2.15M for South American exploration and development

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News